InvestorsHub Logo
Followers 38
Posts 4411
Boards Moderated 0
Alias Born 05/12/2004

Re: lazoom post# 35337

Friday, 10/16/2020 5:51:42 PM

Friday, October 16, 2020 5:51:42 PM

Post# of 198702
ENZC 95% HIV Success. 1/2 Trillion$ Spent on HIV/AIDS:
http://www.healthdata.org/news-release/first-long-term-study-finds-half-trillion-dollars-spent-hivaids

BioClonetics is in the final stage of development of a parent monoclonal antibody ("mAbs") (designated as Clone 3), which is non-toxic and has shown in initial in vitro testing to be effective against more than 95% of all strains and viral subtypes of HIV-1 against which it has been tested.

https://www.accesswire.com/610379/Enzolytics-Inc-Announces-Execution-of-Binding-Letter-of-Intent-for-Merger-with-BioClonetics-Immunotherapeutics-Inc

Letter of Intent Executed!!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News